Purpose: To evaluate in a multi-institutional study whether radiomic features useful for prostate cancer (PCa) detection from 3 Tesla (T) multi-parametric MRI (mpMRI) in the transition zone (TZ) differ from those in the peripheral zone (PZ). Materials and Methods: 3T mpMRI, including T2-weighted (T2w), apparent diffusion coefficient (ADC) maps, and dynamic contrast-enhanced MRI (DCE-MRI), were retrospectively obtained from 80 patients at three institutions. This study was approved by the institutional review board of each participating institution. First-order statistical, cooccurrence, and wavelet features were extracted from T2w MRI and ADC maps, and contrast kinetic features were extracted from DCE-MRI. Feature selection was performed to identify 10 features for PCa detection in the TZ and PZ, respectively. Two logistic regression classifiers used these features to detect PCa and were evaluated by area under the receiver-operating characteristic curve (AUC). Classifier performance was compared with a zone-ignorant classifier. Results: Radiomic features that were identified as useful for PCa detection differed between TZ and PZ. When classification was performed on a per-voxel basis, a PZ-specific classifier detected PZ tumors on an independent test set with significantly higher accuracy (AUC 5 0.61-0.71) than a zone-ignorant classifier trained to detect cancer throughout the entire prostate (P < 0.05). When classifiers were evaluated on MRI data from multiple institutions, statistically similar AUC values (P > 0.14) were obtained for all institutions. Conclusion: A zone-aware classifier significantly improves the accuracy of cancer detection in the PZ. Level of Evidence: 3 Technical Efficacy: Stage 2
P
rostate MRI provides excellent contrast of anatomic structures on T2-weighted (T2w) MRI, as well as diffusion characteristics and microvasculature on diffusionweighted (DW) MRI and dynamic contrast-enhanced (DCE) MRI, respectively. 1 However, up to one quarter of prostate cancers in the transition zone (TZ) might not be detected on MRI, primarily due to the presence of benign tumor confounding pathologies such as benign prostatic hyperplasia. 2 Additionally, areas of benign stroma or hyperplasia may manifest as restricted diffusion on DW MRI and heterogeneous enhancement on DCE MRI. 3 As a result, functional imaging (DW MRI, DCE MRI) is not necessarily useful for detecting TZ tumors.
Computer-assisted diagnosis (CAD) tools provide increased sensitivity and specificity in detecting prostate cancer on multi-parametric MRI, to complement radiologists' assessments. 4 Recently, there has been substantial interest in the role of computer-extracted (or radiomic) texture features to quantitatively describe tissue microarchitecture and morphology. Several CAD approaches have used textural features, including first-and second-order co-occurring statistical measurements, from T2w and diffusion weighted MRI and kinetic features from DCE MRI for prostate cancer detection. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Although many CAD studies have been published over the past decade, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] these studies focus on imaging data from a single institution. In order for a CAD algorithm to be generally useful, however, it must be robust to differences in MR imaging parameters. This is a particularly important consideration because MRI parameters and scanning protocols are not standard across institutions. Furthermore, the variance (or drift) in MRI parameters (T1w, T2w, Diffusion) across vendor platforms and scanners is wellknown and documented. 18 Therefore, it is important to identify radiomic features and develop associated CAD algorithms that are robust to this variability induced by differences in MR imaging parameters across scanners and vendor platforms. The prostate gland can be divided into three primary anatomical regions: the peripheral zone (PZ), the TZ, and the central zone. Prostate cancer in the central zone is rare. 19 While some CAD approaches are designed to look for prostate cancer only in the PZ [7] [8] [9] 20, 21 or TZ, 10,11 many approaches tend to be zone-ignorant. However, the appearance of prostate cancer on MRI tends to depend on the tumor's location in the prostate gland. 5, 6 Whereas PZ tumors usually manifest on T2w MRI as round or illdefined hypointense lesions, TZ tumors are usually moderately hypointense, lenticular-shaped lesions, often with spiculated margins. 22 Additionally, radiomic texture features extracted from T2w MRI, as well as ADC maps and DCE MRI, for characterizing TZ tumors have been shown to be different from those characterizing PZ tumors on multiparametric MRI. 5, 6 Although there has been some recent work on identifying zone-specific radiomic features associated with prostate cancer in the TZ and PZ, 5, 6 these limited studies have been specific to a single institution, and the resilience of these features was not evaluated in a cross-institutional setting. The purpose of this work was to evaluate in a multiinstitutional study whether radiomic features for prostate cancer detection from multi-parametric 3 Tesla (T) MRI in the TZ are similar to the features that are useful for prostate cancer detection in the PZ.
Materials and Methods

Patients
This retrospective study included 87 patients from three institutions (Turku University Hospital, Turku, Finland; St. Vincent's Hospital, Sydney, Australia; and Mt. Sinai Hospital, New York) and was approved by the institutional review board of each institution. Patients from Turku University were part of a previously completed prospective study 23 or were enrolled in an ongoing prospective clinical trial (Clinical Trial registration: NCT02002455). All patients underwent multi-parametric MRI due to suspicion for prostate cancer either before prostate biopsy (52 patients) 23 or before radical prostatectomy (35 patients). Five patients from the former group were excluded due to poor quality of MRI, and two patients were excluded because complete multi-parametric MRI was not performed. Whole-mount prostatectomy specimens were also available for the 35 patients who underwent radical prostatectomy following MRI, as well as 18 patients who underwent prebiopsy MRI but subsequently underwent radical prostatectomy. Thus, a total of 80 patients were included (age range, 40-79 years; median, 64 years); radical prostatectomy specimens were available for 51 of these patients. Further details regarding the patients included in this study can be found in Table 1 .
MRI Acquisition
MRI was performed with a 3 Tesla (T) MR scanner either with a body coil (67 patients) or an endorectal coil (13 patients). The multi-parametric MRI protocol consisted of T2-weighted imaging, diffusion-weighted imaging, and dynamic contrast-enhanced imaging. MRI acquisition details are listed in Table 1 .
Histopathological Analysis and Cancer Annotation on MRI
For subjects from Turku University who underwent radical prostatectomy following MRI acquisition, whole mount prostatectomy sections were obtained, processed as described in Jambor et al, 24 and stained with hematoxylin and eosin. All of the histopathologic material was analyzed by one genitourinary pathologist (8 years of experience in genitourinary pathology) in consensus with another pathologist (6 years of experience in genitourinary pathology). The Gleason score was assigned as a combination of primary, secondary, and tertiary Gleason grades according to the 2005 International Society of Urological Pathology Modified Gleason Grading System. 25 A tertiary Gleason grade was assigned when a Gleason grade pattern higher than the primary and secondary Gleason grade patterns was present but accounted for less than 5% of the tumor. 26 Following histopathological analysis, the histologic slides (50 3 75 mm 2 ) were digitized in 2400 dpi resolution using a high resolution scanner.
To obtain "ground truth" annotation of prostate cancer extent on MRI, deformable co-registration of MRI and whole mount histological sections was performed. Correspondences between histological sections and T2w MRI slices were determined by a genitourinary pathologist and radiologist working in unison. Subsequently, corresponding histological sections and MRI slices were co-registered using an interactive B-spline elastic registration scheme. 27 The final result was a labeling of each MRI voxel within the prostate as corresponding to cancer or benign prostate tissue.
Cancer Annotation on Prebiopsy MRI
For the 29 subjects who did not undergo radical prostatectomy following MRI acquisition, ground truth for prostate cancer extent from excised surgical histopathology was not available. These included 16 subjects from St. Vincent's Hospital and 13 subjects from Mt. Sinai Hospital. For the subjects from St. Vincent's, a genitourinary radiologist (9 years of experience) assessed multiparametric MRI for cancer presence and annotated prostate cancer extent, if present, on T2w MRI. For the subjects from Mt. Sinai, a genitourinary radiologist (5 years of experience) annotated the 
MRI Postprocessing
DCE MRI and ADC maps 24 obtained from DWI were spatially aligned with T2w MRI by means of volumetric affine registration, which corrected inter-acquisition movement and inter-protocol resolution differences. After inter-protocol alignment, all MRI data from all institutions were computationally analyzed at the T2w MRI resolution of 0.625 3 0.625 3 3 mm 2 . The prostate capsule and TZ were manually annotated on T2w MRI by a radiologist with 7 years of experience in prostate MRI. Finally, T2w and DCE MRI were corrected for acquisition-based MRI intensity artifacts. 28 We first corrected for intensity inter-and intra-patient T2w MRI "intensity drift", which causes T2w MRI intensities to lack tissuespecific numeric meaning. 18 This effect was corrected by interactive implementation of the generalized scale algorithm, 18 which aligns image intensity histograms across different MRI studies, thereby enabling MRI intensities to have a consistent tissue-specific numeric meaning. Additionally, for patients who were imaged using an endorectal probe, the bias field artifact occurring on T2w and DCE MRI was corrected by the N3 algorithm. 29 
Radiomic Features
Our feature set included signal intensities on T2w MRI, ADC values, and six kinetic features describing the uptake and washout of contrast on DCE MRI (see Table 2 ). In addition, 224 radiomic features (see Table 2 ), including edge descriptors [32] , first-order statistical [32] , co-occurrence [33] , and Gabor [34] and Haar [35] wavelet features computed from both T2w MRI and ADC maps, were extracted. These features are designed to accentuate smooth and spiculated margins and to differentiate between homogeneous regions of low signal intensity associated with prostate cancer and surrounding normal prostate tissue.
Identifying Features for Discriminating Cancerous From Benign Voxels
Radiomic features were selected based on (a) resilience and lack of variability between patients and institutions and (b) ability to discriminate between cancerous and benign prostate voxels. Feature resilience across patients and institutions was determined based on Cronbach's intra-class correlation coefficient (ICC), 30 which measures the level of concordance in feature values. Features associated with an ICC > 0.9 were considered resilient to inter-patient and inter-institutional differences. For each feature identified as resilient, binary logistic regression was implemented to classify individual voxels as cancerous or benign, and the area under the receiver-operating characteristic (ROC) curve (AUC) was calculated based on the posterior probabilities of a voxel being classified as cancerous. Finally, features associated with both the highest AUC values and ICC > 0.9 were identified as being useful for characterizing prostate cancer in a multi-institutional setting. Two separate sets of features were identified: one set of features that characterizes TZ cancers (F TZ ) and another set of features to characterize PZ cancers (F PZ ).
Additionally, a third set of features was identified that did not specifically consider zonal anatomy (F ALL ). Separate radiomic feature sets were obtained based on patients from Turku University 
Results
Differences in Radiomic Features Between TZ and PZ Classifiers
The top 10 radiomic features selected for detecting TZ and PZ tumors are listed in yielded AUC values ranging between 0.61 and 0.71, although these classifiers yielded lower AUC values when applied to studies in I 3 (0.54-0.58; see Table 4 Table 4 ). There were no statistically significant differences in AUC values between C ALL and C TZ . 
Correlation with Gleason Scores
Effect of Training Cohort on Classifier Performance
A two-sample Student's t-test was used to evaluate whether statistically significant differences existed between AUC values yielded by C 
Discussion
In this study, we identified and evaluated radiomic features associated with TZ and PZ tumors on multi-parametric MRI. We found that distinct sets of radiomic features were useful for cancer detection in the TZ and PZ, respectively. Furthermore, the cancer detection accuracy associated with these features was not significantly different across the three institutions considered in this study. Regardless of training cohort, F TZ and F PZ did not overlap at all. This finding suggests that multi-parametric MRI radiomic features identified as useful for cancer Gabor (h 5 detection in the PZ were distinct from radiomic features that are useful for cancer detection in the TZ. 6 The dearth is used and when C PZ 12 and C TZ 12 complement each other to detect cancer in both the PZ and TZ. Red indicates a high probability of cancer presence, yellow indicates a low probability of cancer presence, and blue, the absence of cancer.
of ADC and DCE features in F PZ and F TZ may be related to DWI and DCE MRI data quality.
Accounting for differences between TZ and PZ tumors by identifying unique feature sets F TZ and F PZ and subsequently developing distinct classifiers C TZ and C PZ led to significantly improved cancer detection in the PZ. C PZ yielded voxel-wise AUC values as high as 0.71, whereas C ALL performed no better than random guessing (AUC 0.51). In contrast to the PZ, in the TZ C TZ and C ALL performed similarly to each other, providing AUC values ranging between 0.54 and 0.68. This result may possibly be due to the inherent difficulty in distinguishing between tumors in the TZ and confounding disease, such as benign prostatic hyperplasia, that manifests predominantly in the TZ.
The AUC values associated with C TZ and C PZ were lower than those obtained in other studies, 4 ,5 which reported voxel-wise AUC values as high as 0.73-0.86 for cancer detection in the PZ and/or TZ. However, the results reported in Ginsburg et al and Viswanath et al 5, 6 were all based on cross-validation within a single institution. Our lower AUC could possibly be attributed to the fact that 75% of the tumors in our cohort were < 1 cm 3 in size. Nevertheless, 80% of small tumors that were clinically significant (Gleason score > 7) were detected on MRI. The AUC values correlated somewhat with tumor size, as larger tumors were associated with higher AUC values (see Fig. 2c ). The correlation between Gleason scores and AUC values for all tumors from I 1 was poor in both the TZ and PZ (see Figs. 2a,b) . This is not surprising because the classifiers were trained to discriminate between prostate cancer and benign tissue; they were not trained to distinguish between cancer grades. Our study did have its limitations. First, this was a multi-institutional study. While this was a unique aspect of our study, it was also a limitation because the MRI acquisition parameters (e.g., b-values for acquiring diffusionweighted MRI, temporal resolution of DCE MRI) differed between institutions. This lack of consistency may explain why primarily T2-weighted MRI features were chosen during feature selection, whereas most ADC-and DCE-based features were not highly ranked by our feature selection scheme. Nevertheless, our study demonstrated that radiomic features can be effective for prostate cancer detection even in the face of variability in image acquisition parameters. Second, whereas the MRI data from I 1 and I 2 was acquired using a body coil, the MRI data from I 3 was acquired using an endorectal coil. This may have contributed to the lower cancer detection accuracy associated with I 3 , particularly in the PZ, where the effect of the endorectal coil would be most seen. Finally, for 29 subjects in our cohort, ground truth prostate cancer extent on pathology was not available. For 13 of these subjects, prostate cancer extent was annotated on MRI based on correlation with fusion targeted biopsy results, but for the remaining 16 subjects a genitourinary radiologist annotated prostate cancer extent based on visual assessment of multi-parametric MRI alone. In the absence of pathology fused with MRI, it was not possible to be certain of the exact extent of prostate cancer for these cases.
In conclusion, the radiomic features identified as useful for cancer detection in the PZ were different from those that were useful for TZ cancers. These features were evaluated cross-institutionally and found to be useful for prostate cancer detection on MRI from three institutions. Our finding that a zone-aware classifier significantly improves the accuracy of cancer detection in the PZ suggests that decision support tools for evaluating prostate MRI exams should take into account differences between TZ and PZ tumors.
